Kymera Therapeutics, Inc.
KYMR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001815442
In the last 90 days, Kymera Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 276 institutions reported holding it in 13F filings for Q2 2026, worth $11.1B in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Kymera Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 122
- −7 vs. Q2 2023
- Shares held
- 57.4M
- −1.07M (−1.8%) vs. Q2 2023
- Total value
- $797.2M
- −$546.7M (−40.7%) vs. Q2 2023
- New holders
- 12
- 49 more added
- Sold out
- 19
- 37 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KYMR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 276 | $11.1B |
| Q1 2026 | 256 | $8.01B |
| Q4 2025 | 255 | $6.99B |
| Q3 2025 | 210 | $4.58B |
| Q2 2025 | 210 | $3.44B |
| Q1 2025 | 174 | $2.00B |
| Q4 2024 | 181 | $2.89B |
| Q3 2024 | 176 | $3.27B |
| Q2 2024 | 157 | $2.01B |
| Q1 2024 | 164 | $2.70B |
| Q4 2023 | 137 | $1.54B |
| Q3 2023 | 122 | $797.2M |
| Q2 2023 | 129 | $1.34B |
| Q1 2023 | 127 | $1.68B |
| Q4 2022 | 121 | $1.40B |
| Q3 2022 | 128 | $1.15B |
| Q2 2022 | 101 | $973.6M |
| Q1 2022 | 126 | $1.93B |
| Q4 2021 | 128 | $2.76B |
| Q3 2021 | 115 | $2.04B |
| Q2 2021 | 110 | $1.29B |
| Q1 2021 | 97 | $887.2M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Kymera Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Massachusetts Financial Services Co | 463,533 | $6.44M | 0.00% | +86,585+23.0% | Added |
| Candriam Luxembourg S.C.A. | 488,306 | $6.79M | 0.06% | 00.0% | Unchanged |
| Wasatch Advisors Inc | 572,907 | $7.96M | 0.05% | −626,443−52.2% | Reduced |
| Deer Management Co. LLC | 615,895 | $8.56M | 1.04% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 621,992 | $8.65M | 0.00% | −33,979−5.2% | Reduced |
| Dimensional Fund Advisors LP | 655,227 | $9.11M | 0.00% | −185,711−22.1% | Reduced |
| Aquilo Capital Management, LLC | 782,219 | $10.9M | 9.85% | +130,894+20.1% | Added |
| Geode Capital Management, LLC | 834,227 | $11.6M | 0.00% | +32,942+4.1% | Added |
| FMR LLC | 870,547 | $12.1M | 0.00% | +32,335+3.9% | Added |
| Rock Springs Capital Management LP | 1,504,351 | $20.9M | 0.56% | +16,800+1.1% | Added |
| T. Rowe Price Investment Management, Inc. | 1,610,496 | $22.4M | 0.02% | 00.0% | Unchanged |
| Artal Group S.A. | 1,805,346 | $25.1M | 1.09% | 00.0% | Unchanged |
| Redmile Group, LLC | 1,868,507 | $26.0M | 1.24% | 00.0% | Unchanged |
| State Street Corp | 1,985,886 | $27.6M | 0.00% | −634,423−24.2% | Reduced |
| BlackRock Inc. | 3,357,884 | $46.7M | 0.00% | +132,038+4.1% | Added |
| Avoro Capital Advisors LLC | 3,855,000 | $53.6M | 0.84% | 00.0% | Unchanged |
| Vanguard Group Inc | 3,925,213 | $54.6M | 0.00% | +182,125+4.9% | Added |
| BVF Inc | 4,739,004 | $65.9M | 1.78% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 4,750,400 | $66.0M | 0.38% | +375,060+8.6% | Added |
| Wellington Management Group LLP | 4,823,329 | $67.0M | 0.01% | +6460.0% | Added |
| Price T Rowe Associates Inc | 5,057,425 | $70.3M | 0.01% | +50,277+1.0% | Added |
| Atlas Venture Life Science Advisors, LLC | 5,858,262 | $81.4M | 12.61% | 00.0% | Unchanged |
| HRT Financial LP | 0 | $0 | 0.00% | −73,516−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −52,043−100.0% | Sold out |
| Ghisallo Capital Management LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −39,133−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −26,591−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −25,840−100.0% | Sold out |
| Healthcare of Ontario Pension Plan Trust Fund | 0 | $0 | 0.00% | −20,848−100.0% | Sold out |
| B. Metzler seel. Sohn & Co. AG | 0 | $0 | 0.00% | −16,608−100.0% | Sold out |
| Duality Advisers, LP | 0 | $0 | 0.00% | −16,600−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −11,530−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −9,648−100.0% | Sold out |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −9,014−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −150−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −113−100.0% | Sold out |
| Impact Partnership Wealth, LLC | 0 | $0 | 0.00% | −48−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| Bell Investment Advisors, Inc | 0 | $0 | 0.00% | −21−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |